<unk>  is a tyrosine kinase nhibitor that is FDA approved for the treatment of non small cell lung cancer (NSCLC), pancreatic cancer.   Common adverse reactions include edema，alopecia，pruritus，rash，decreased weight，abdominal pain，diarrhea，flatulence, indigestion，inflammatory disease of mucous membrane，loss of appetite，nausea，vomiting, hyperbilirubinemia, increased liver enzymes，infectious disease，bone pain，myalgia，headache，conjunctivitis, keratoconjunctivitis sicca，anxiety，depression，cough，dyspnea，fatigue, fever..
Erlotinib
Nilotinib
Afatinib
Axitinib
Sunitinib
Crizotinib
Gefitinib
Neratinib